Stable, Injectable Noradrenaline Solutions Free Of Antioxidants

Patent No. EP4051251 (titled "Stable, Injectable Noradrenaline Solutions Free Of Antioxidants") was filed by Sintetica on Sep 29, 2021. The application was issued on Aug 23, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ZINNERMay 17, 2024ZINNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4051251

SINTETICA
Application Number
EP21783523A
Filing Date
Sep 29, 2021
Status
Granted And Under Opposition
Jul 21, 2023
Publication Date
Aug 23, 2023